Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on December 20, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,638 cr
Turnover Ratio
16.09%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 2.84%
- 1Y: 37.71%
- 3M: -0.54%
- 3Y: 21.99%
- 6M: 15.76%
- 5Y: 28.83%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
41.620 | 50.42% | 5,024 cr | 1.09% | - | ||
484.162 | 45.57% | 3,460 cr | 0.89% | - | ||
35.526 | 44.44% | 1,208 cr | 0.69% | - |
Other plans of Nippon India Pharma